13F Holdings
中文EN

MYO MYOMO, INC.

Orthopedic, Prosthetic & Surgical Appliances & Supplies · NYSE · SEC CIK 1369290 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY9.3%
TTM net income YoY-25.4%
TTM EPS YoY-25.0%
Revenue 3-yr CAGR34.9%
Net income 3-yr CAGR—

Margins

Gross margin70.1%
Operating margin-21.8%
Net margin-33.1%
FCF margin-12.7%
EBITDA margin-18.8%

Returns

ROE-173.5%
ROA-44.4%
ROIC (approx.)-154.0%
Asset turnover1.34x

Leverage & solvency

Liabilities / assets91.9%
Debt / equity4.89x
Current ratio1.92x
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.44x
Accruals ratio-25.0%
Payout ratio—
Capex / revenue-1.8%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue$40.93M$32.55M$19.24M$15.56M$13.86M
Cost of revenue$14.04M$9.37M$6.06M$5.30M$3.54M
Gross profit$26.89M$23.19M$13.18M$10.25M$10.31M
R&D expense$6.94M$4.77M$2.64M$2.48M$2.56M
SG&A expense$13.96M$12.38M$9.73M$18.44M$18.02M
Operating income-$14.40M-$6.21M-$8.23M-$10.67M-$10.27M
Pretax income-$15.07M-$5.82M-$7.99M-$10.65M-$10.28M
Income tax$504,532$365,617$156,002$69,937$88,928
Net income-$15.57M-$6.18M-$8.15M-$10.72M-$10.37M
EBITDA-$13.54M-$6.00M-$8.07M-$10.48M-$10.12M
EPS (basic)-0.37-0.16-0.28-1.52-1.89
EPS (diluted)-0.37-0.16-0.28-1.52-1.89
Weighted avg. shares (diluted)41.86M37.76M29.50M7.05M5.83M
Balance sheet
Cash & equivalents$14.13M$24.37M$6.87M$5.35M$15.52M
Short-term investments$4.26M$492,990$1.99M$0—
Receivables$4.10M$3.83M$2.38M$1.90M$1.96M
Inventory$3.12M$3.17M$1.80M$1.40M$808,308
Current assets$27.56M$32.79M$13.65M$9.22M$19.09M
PP&E, net$2.21M$1.33M$175,794$194,283$275,289
Total assets$38.64M$42.24M$14.58M$10.16M$20.10M
Current liabilities$8.35M$10.17M$5.48M$3.60M$4.28M
Short-term debt$0$2.95M———
Long-term debt$11.22M$11.22M———
Total debt$11.22M$14.18M———
Total liabilities$27.23M$17.53M$5.59M$3.80M$4.69M
Shareholders' equity$11.40M$24.71M$8.99M$6.36M$15.41M
Net debt-$2.91M-$10.20M———
Shares outstanding38.47M34.38M27.14M7.75M6.87M
Cash flow statement
Operating cash flow-$14.51M-$3.29M-$6.17M-$10.23M-$9.55M
Capital expenditure$1.74M$1.36M$145,816$111,793$326,462
Free cash flow-$16.25M-$4.65M-$6.32M-$10.35M-$9.87M
Investing cash flow-$7.06M$259,981-$2.03M-$310,793-$326,462
Financing cash flow$11.43M$20.93M$9.71M$376,858$13.17M
Depreciation & amortization$859,354$205,910$164,306$192,799$145,995
Stock-based compensation$2.08M$874,438$1.12M$1.19M$1.10M

Free plan shows the latest 5 periods; Pro shows all 10 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.